CRP and neoplasm: Plasma CRP has been proposed as a sensitive serological surrogate parameter for elevated levels of proinflammatory cytokines stimulating angiogenesis, tumor proliferation, and growth, being an easily measurable biomarker, which is routinely analyzed before treatment initiation [50,51].